Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03090230 · ClinicalTrials.gov registry record · NA
Study of the Relay Pro® Thoracic Stent-Graft in Subjects With Traumatic Injury of the Descending Thoracic Aorta
A NA study of Other Specified Injury of Thoracic Aorta, sponsored by Bolton Medical.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 16
- Study locations
NCT03090230: Active NA study of Other Specified Injury of Thoracic Aorta, sponsored by Bolton Medical.
NCT03090230 is a NA study of Other Specified Injury of Thoracic Aorta that is active but no longer recruiting, run by Bolton Medical. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 16 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03090230, a NA study of Other Specified Injury of Thoracic Aorta, is active but no longer recruiting, sponsored by Bolton Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 16
- Study locations
Study Summary
The purpose of this study is to investigate the safety and effectiveness of the RelayPro Thoracic Stent-Grafts in subjects with traumatic injury of the descending thoracic aorta (DTA)
Primary Outcome
All-cause mortality at 30 days post-procedure
Conditions Studied
Interventions
- DEVICE Relay Pro Thoracic Stent-Graft System
Study Locations (16)
California
- University of California, Irvine - Irvine
- Stanford Medicine - Stanford
Connecticut
- Yale School of Medicine - New Haven
Georgia
- Grady Memorial Hospital - Atlanta
Indiana
- Indiana University Health - Indianapolis
Iowa
- University of Iowa Hospital and Clinic - Iowa City
Maryland
- University of Maryland Medical Center - Baltimore
Massachusetts
- Beth Israel Deaconess Medical Center / Harvard Medical School - Boston
Missouri
- St. Louis University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-04-17 |
| Est. Completion | 2025-11-22 |
| Phase | NA |
What the registry record for NCT03090230 still lists
NCT03090230 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Other Specified Injury of Thoracic Aorta appearing as the primary indexed condition, and to 1 intervention - of which Relay Pro Thoracic Stent-Graft System is the first listed.
NCT03090230 lists 16 locations in 15 states (California, Connecticut, Georgia).
Frequently Asked Questions
What is clinical trial NCT03090230 about?
NCT03090230 is a clinical study titled "Study of the Relay Pro® Thoracic Stent-Graft in Subjects With Traumatic Injury of the Descending Thoracic Aorta". The purpose of this study is to investigate the safety and effectiveness of the RelayPro Thoracic Stent-Grafts in subjects with traumatic injury of the descending thoracic aorta (DTA)
What is the current status of trial NCT03090230?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2017-04-17. Estimated completion is 2025-11-22.
What conditions does trial NCT03090230 study?
This clinical trial studies the following conditions: Other Specified Injury of Thoracic Aorta.
What interventions are being tested in trial NCT03090230?
The interventions under investigation include: Relay Pro Thoracic Stent-Graft System (DEVICE).
Who is sponsoring clinical trial NCT03090230?
This trial is sponsored by Bolton Medical, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03090230 being conducted?
This trial has 16 study locations across California, Connecticut, Georgia, Indiana, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03090230's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI